Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies
Clinical trial NCT00857389 · COMPLETED
Trial details
- NCT number
- NCT00857389
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-02
- Primary completion
- 2019-03-09
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.